ScholarIQanswers from OpenAlex

A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure

PaperCitations, authors & open-access status

A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure have?

ScholarIQcitation count

A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure has 615 citations in the OpenAlex counts ScholarIQ stores.

When was A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure published?

ScholarIQyear

A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure has 1998 year in the ScholarIQ index.

What is the open-access status of A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure?

ScholarIQoa status

A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure has closed oa status in the ScholarIQ index.

What is the DOI of A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure?

ScholarIQdoi

The DOI for A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure is on the source record.

What is the PMID of A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure?

ScholarIQpmid

The PMID for A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure is on the source record.

What is the OpenAlex record for A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure?

ScholarIQopenalex

The OpenAlex for A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial